1 asset in Leber Plus Disease
Therapeutic assets addressing Leber Plus Disease, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Glycerol Tributyrate Leber Plus Disease | George Washington University | P1/2 | NR () |